Advaita Bioinformatics News
A leader in the interpretation of high-throughput biomedical data.
iPathwayGuide’s prediction for a COVID-19 drug validated in clinical study
Methylprednisolone effective in treating critically ill patients We recently announced that Advaita’s advanced AI platform, iPathwayGuide, has identified an existing drug with clinical efficacy against COVID-19. An independent clinical study undertaken at HFHS and led by Dr. Mayur S. [...]
Advaita’s iPathwayGuide provides a cost-effective alternative to Ingenuity Pathway Analysis (IPA) on Yet Another Continent
Inqaba Biotechnical Industries partners with Advaita Bioinformatics to provide advanced pathway analysis software in Sub-Saharan Africa ANN ARBOR, MI – October 14, 2019— Advaita Bioinformatics, the leader in the interpretation of high-throughput biomedical data, today announced a new distribution partnership [...]
What’s the difference between iPathwayGuide and Ingenuity Pathway Analysis (IPA)?
You might think that spending thousands of dollars to meet your bioinformatics needs guarantees the most accurate analysis on the market. Well, it’s actually a lot more complicated than that! Expensive pathway analysis tools such as Qiagen’s Ingenuity Pathway Analysis [...]
iPathwayGuide is Perfect for Bioinformatics Cores and Service Providers
Is this you? You provide expert bioinformatics services to your organization You have great analysts in your group, but not enough of them Your organization does extremely important work in biomedical research, but you have to live on a budget [...]
Not getting much from your pathway analysis? Use Impact Analysis instead of Enrichment alone.
How are you currently analyzing your RNASeq and proteomics data? Are you currently using one of the many free tools available for pathway analysis, such as DAVID? Or, are you perhaps using Qiagen's IPA? If yes, you are using an [...]
Advaita is taking the lead…
You may be interested this recent story in GenomeWeb about how Advaita is taking the lead in the pathway analysis of RNASeq and proteomics data. We are excited that more and more people are gaining access to iPathwayGuide and iVariantGuide. [...]
Advaita Scientists Awarded Another Pathway Analysis Patent
A while ago, I was doing the pathway analysis of a data set coming from a fat remodeling experiment in mice. This experiment involved a drug candidate known to transform the "regular fat" or white adipose tissue into "brown fat" [...]
iPathwayGuide Analysis Finds Both Overlapping and Species-Specific Endocrine Disrupting Chemical Response Signatures in Sardine and Mackerel
Orthologs in Systems Biology A recent paper by Renaud, et al., (Environmental Pollution, Vol 244, January 2019, pp 926-937) points out the significant hazard posed by endocrine disrupting chemical (EDC) exposure for aquatic organisms. Renaud, et al., employed iPathwayGuide as [...]
Advaita Bioinformatics displaces major competitor in Australia and New Zealand
Advaita announces new distribution partnership with Millennium Science. ANN ARBOR, Michigan, April 23, 2019 – Advaita Bioinformatics, provider of the industry-leading gene expression and genomic variation analysis platform, announces a new partnership with Millennium Science for distribution of Advaita’s software [...]
How do you validate a pathway analysis method? How do you compare such methods?
My previous blog ended with an interesting question: has anybody really compared side-by-side gene set analysis methods and pathway analysis methods on the same data sets? Well, the answer is: not yet! The main reason for this is that it [...]
Pathway Analysis vs Gene Set Analysis: What is the Difference and When Should I Use Each?
Once upon a time, the dream of many a life scientist was simply to be able to measure all gene expression changes involved in a comparison of two phenotypes. “If we could only measure all these changes, it would be [...]
Subscription vs. purchasing individual analyses – which one do I want?
Several of our customers have asked us this question: "I am not a core facility, nor do I have a huge lab and therefore I do not have a lot of RNA-Seq data. Should I buy a subscription to iPathwayGuide [...]
AdvaitaBio releases a new version of iPathwayGuide, the world’s most advanced RNA-seq and gene expression analysis software
Advaita Bioinformatics is announcing a new release of iPathwayGuide, the world’s most advanced RNA-seq and gene expression analysis software. This release includes unprecedented gene network analysis and literature mining capabilities. The newly added network analysis capabilities allow the scientists to [...]
Wayne State and Advaita Researchers Can Distinguish Between Aggressive and Less Aggressive Cancer
Advaita Bioinformatics is a leader in the interpretation of high-throughput biomedical data including variant interpretation, pathway analysis, and disease subtype discovery. In a breakthrough in cancer diagnosis, a technology developed by a team of researchers from Wayne State University and [...]
Advaita Bioinformatics Awarded Competitive Grant from the National Science Foundation
Plymouth, MI (August 13, 2017 )– Advaita Bioinformatics, one of the most innovative companies in the field of Genomics, has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant of $225,000 to conduct research and development [...]
